Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph early_phase_1
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed350%
recruiting233%
unknown117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
6